Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.46 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Receivables - Other came in at $104,053 for the quarter ended Dec 31, 2025, up 1.3% from $102,741 a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Receivables - Other was -$23.39 million.

  • Going back by year, Receivables - Other was $360,000 in the year ended Dec 31, 2024 (+95.4%) and $184,236 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Zhengye Biotechnology Holding 70.08 Mn 58.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 105,487.34
Jun 30, 2025 103,000.00
Dec 31, 2024 101,122.21
Dec 31, 2023 183,199.66
API Access

Zhengye Biotechnology Holding Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ZYBT&period=max&api_key=YOUR_API_KEY